antimicrobial resistance
Day Zero Diagnostics Aiming to Bring Whole-Genome Sequencing Pathogen ID/AST to Clinical Labs
Premium
The firm intends to use new funding to move its platform into the clinical trial stage in the pursuit of an FDA-regulated IVD product.
Curetis, FIND Extend Antimicrobial Resistance Research Collaboration
The extended partnership covers the development of an AMR assay, a cartridge for the Unyvero A30 platform, and a software plug-in.
Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Premium
Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies.
Sepsis Testing Startup DeepUll Raises €13M
The diagnostics firm is developing a culture-free system for guiding treatment selection for sepsis patients.
The finding underscores the need to standardize sampling protocols to minimize biases in wastewater antimicrobial resistance monitoring.